KLK3 and prostate cancer: Herein, we assess whether advanced computational analysis of peripheral blood flow cytometry immunophenotyping data from a selected cohort of individuals can generate prediction models with potential clinical value and identify the presence of prostate cancer in asymptomatic individuals with a PSA level <20 ng ml−1.